Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The use of aminopyridines in neurological disorders.
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
Noninvasive molecular imaging of neuroinflammation.
Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis.
Placebo? no thanks, it might be bad for me!
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment.
IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-Aquaporin 4 antibodies.
Pelvic Floor Muscle Training With and Without Electrical Stimulation in the Treatment of Lower Urinary Tract Symptoms in Women With Multiple Sclerosis.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Axonal transport analysis using Multitemporal Association Tracking.
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis (PROMESS)
Laquinimod Halted MS Disability But Not Relapses
Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Segway use in individuals with multiple sclerosis.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
[Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a german high-volume clinic].
Disease-modifying therapies in Chinese children with multiple sclerosis.
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.

Pages